AnalystsDonald Ellis
Donald Ellis's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 46%
#2693 out of 4871 analysts
Average Return
+13.79%
Win Rate
100%1 out of 1
Risk vs Reward
Poor
Good

Donald Ellis's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Revance Therapeutics IncRVNC
+13.79%$23.20$26.40
2017-08-21 -
2018-08-22
Buy

Donald Ellis Analyst Color

Get additional color on Donald Ellis's coverage of popular stocks

Donald Ellis's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Revance Therapeutics IncRVNC
2HoldN/AN/ADowngrades
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.